Steven L Bernstein Selected Research

Personality Disorders (Personality Disorder)

4/2016

Influence of Psychiatric and Personality Disorders on Smoking Cessation Among Individuals in Opiate Dependence Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven L Bernstein Research Topics

Disease

16	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2024 - 10/2007
7	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 04/2015
7	Ischemia 01/2021 - 10/2003
6	Tobacco Use Disorder (Nicotine Dependence) 04/2024 - 02/2006
6	Neoplasms (Cancer) 01/2023 - 01/2020
6	Infarction (Infarctions) 01/2012 - 10/2007
5	Edema (Dropsy) 01/2021 - 11/2013
4	Stroke (Strokes) 01/2016 - 10/2003
3	COVID-19 11/2023 - 01/2023
3	Infections 01/2022 - 03/2005
3	Pain (Aches) 08/2021 - 03/2006
2	Glaucoma 11/2019 - 03/2006
2	Inflammation (Inflammations) 11/2019 - 12/2013
2	Opiate Overdose 04/2019 - 11/2018
1	Asthma (Bronchial Asthma) 01/2022
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Hypotension (Low Blood Pressure) 01/2020
1	Nausea 01/2019
1	Neuroinflammatory Diseases 01/2017
1	Personality Disorders (Personality Disorder) 04/2016
1	Atrophy 02/2016
1	Retinal Hemorrhage 12/2015
1	Ganglion Cysts (Ganglion) 01/2015
1	Optic Nerve Injuries 01/2015
1	Optic Nerve Diseases (Optic Neuropathy) 01/2015
1	Hypoventilation 01/2015
1	Hyperlipidemias (Hyperlipidemia) 09/2013
1	Bipolar Disorder (Manic Depressive Psychosis) 09/2013
1	Mental Disorders (Mental Disorder) 09/2013
1	Hypertension (High Blood Pressure) 09/2013
1	Substance-Related Disorders (Drug Abuse) 09/2013
1	Psychotic Disorders (Schizoaffective Disorder) 09/2013
1	Alcoholism (Alcohol Abuse) 01/2013
1	Macular Degeneration (Age-Related Maculopathy) 01/2013
1	Thrombosis (Thrombus) 05/2011
1	type 1D Usher syndrome 09/2009
1	Retinal Degeneration 09/2009

Drug/Important Bio-Agent (IBA)

9	Retinaldehyde (Retinal)IBA 01/2021 - 10/2003
7	SmokeIBA 01/2023 - 02/2006
4	Buprenorphine (Subutex)FDA LinkGeneric 01/2023 - 04/2015
4	Opioid Analgesics (Opioids)IBA 01/2021 - 09/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2005
3	Neuroprotective AgentsIBA 01/2016 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 09/2009 - 10/2003
2	Ciliary Neurotrophic Factor (CNTF)IBA 01/2024 - 01/2015
2	9-deoxy-delta-9-prostaglandin D2IBA 01/2021 - 11/2013
2	Naloxone (Narcan)FDA LinkGeneric 04/2019 - 11/2018
2	CytokinesIBA 01/2017 - 12/2013
2	Coloring Agents (Dyes)IBA 05/2011 - 04/2009
2	Rose BengalIBA 08/2010 - 04/2009
2	Messenger RNA (mRNA)IBA 09/2009 - 10/2003
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2024
1	Nicotine FDA Link 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Nogo ReceptorsIBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Analgesics (Analgesic Drugs)IBA 08/2021
1	lipoarabinomannan (LAM)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	trabodenosonIBA 11/2019
1	Adenosine (Adenocard)FDA LinkGeneric 11/2019
1	AntiemeticsIBA 01/2019
1	RV 538 (PDMP)IBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2017
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2016
1	Sulfonylurea ReceptorsIBA 01/2016
1	Dendrimers (Dendrons)IBA 01/2016
1	Ion Channels (Ion Channel)IBA 01/2016
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2015
1	Ranibizumab (Lucentis)FDA Link 12/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	IonsIBA 05/2015
1	Naloxone Drug Combination Buprenorphine FDA Link 04/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	ProstaglandinsIBA 10/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2013
1	Varenicline (Chantix)FDA Link 09/2013
1	Illicit Drugs (Recreational Drugs)IBA 01/2013
1	fibulinIBA 01/2013
1	Complement Factor H (Factor H)IBA 01/2013
1	Cholinergic Agents (Cholinergics)IBA 02/2011
1	GAP-43 Protein (GAP 43 Protein)IBA 08/2010
1	Cadherins (E-Cadherin)IBA 09/2009
1	Protein Isoforms (Isoforms)IBA 09/2009

Therapy/Procedure

4	Nicotine Replacement Therapy 02/2023 - 01/2018
3	Length of Stay 11/2023 - 01/2022
3	Intravitreal Injections 12/2015 - 11/2013
3	Lasers (Laser) 05/2011 - 04/2009
2	Operative Surgical Procedures 01/2021 - 01/2021
1	Art Therapy 04/2024
1	Hospice Care (Care, Bereavement) 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Patient Readmission 08/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 01/2016